Search Results - Kenta Yoshida

Simulation‐based evaluation of personalized dosing approaches for anti‐FGFR/KLB bispecific antibody fazpilodemab by Kenta Yoshida, Victor Poon, Ajit Dash, Rebecca Kunder, Leslie Chinn, Matts Kågedal

Connect to this object online.

Association between cumulative cisplatin dose and reproductive and sexual functions in patients with malignant ovarian germ cell tumors treated with bleomycin, etoposide, and cispl... by Miki Akasaka, Toshinori Hirai, Kenta Yoshida, Eiji Kondo, Tomoaki Ikeda, Takuya Iwamoto

Connect to this object online.

Benefits of Pelvic and Para-Aortic Lymphadenectomy after Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer with Enlarged Lymph Nodes by Michiko Kubo-Kaneda, Eiji Kondo, Naosuke Enomoto, Kota Okamoto, Kuniaki Toriyabe, Masafumi Nii, Kenta Yoshida, Tomoaki Ikeda

Connect to this object online.

Safety and efficacy of laparoscopic oophorocystectomy for ovarian dermoid cyst associated with autoimmune hemolytic anemia by Masafumi Nii, Eiji Kondo, Shintaro Maki, Michiko Kubo, Kenta Yoshida, Lingyun Zhang, Yoshiyuki Kobayashi, Tsutomu Tabata, Tomoaki Ikeda

Connect to this object online.

PK/PD modeling to characterize placebo and treatment effect of omalizumab for chronic spontaneous urticaria by Elise Oh, Russ Wada, Kha Le, Yanan Zheng, Jin Jin, Victor Poon, Kit Wong, Ryan Owen, Kenta Yoshida

Connect to this object online.

Physiologically‐Based Pharmacokinetic Model‐Informed Drug Development for Fenebrutinib: Understanding Complex Drug‐Drug Interactions by Yuan Chen, Fang Ma, Nicholas S. Jones, Kenta Yoshida, Po‐Chang Chiang, Matthew R. Durk, Matthew R. Wright, Jin Yan Jin, Leslie W. Chinn

Connect to this object online.

A mechanistic PK/PD model to enable dose selection of the potent anti‐tryptase antibody (MTPS9579A) in patients with moderate‐to‐severe asthma by Sharon M. Rymut, Lindsay M. Henderson, Victor Poon, Tracy L. Staton, Fang Cai, Siddharth Sukumaran, Horace Rhee, Ryan Owen, Saroja Ramanujan, Kenta Yoshida

Connect to this object online.

Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition-overall survival modeling framework by Phyllis Chan, Mathilde Marchand, Kenta Yoshida, Shweta Vadhavkar, Nina Wang, Alyse Lin, Benjamin Wu, Marcus Ballinger, Nitzan Sternheim, Jin Y. Jin, René Bruno

Connect to this object online.

Concentration QTc analysis of giredestrant: Overcoming QT/heart rate confounding in the presence of drug‐induced heart rate changes by Logan Brooks, Michael Dolton, Jurgen Langenhorst, Kenta Yoshida, Yi Ting (Kayla), Vikram Malhi, Chunze Li, Pablo Perez‐Moreno, John Bond, Ya‐Chi Chen, Jiajie Yu

Connect to this object online.

Physiologically‐based pharmacokinetic model‐based translation of OATP1B‐mediated drug-drug interactions from coproporphyrin I to probe drugs by Tatsuki Mochizuki, Yasunori Aoki, Takashi Yoshikado, Kenta Yoshida, Yurong Lai, Hideki Hirabayashi, Yoshiyuki Yamaura, Kevin Rockich, Kunal Taskar, Tadayuki Takashima, Xiaoyan Chu, Maciej J. Zamek‐Gliszczynski, Jialin Mao, Kazuya Maeda, Kenichi Furihata, Yuichi Sugiyama, Hiroyuki Kusuhara

Connect to this object online.

Dose‐dependent inactivation of airway tryptase with a novel dissociating anti‐tryptase antibody (MTPS9579A) in healthy participants: A randomized trial by Sharon M. Rymut, Siddharth Sukumaran, Gizette Sperinde, Meire Bremer, Joshua Galanter, Kenta Yoshida, Jordan Smith, Prajna Banerjee, Viyia Sverkos, Fang Cai, Verena Steffen, Lindsay M. Henderson, Horace Rhee, Paula N. Belloni, Joseph H. Lin, Tracy L. Staton

Connect to this object online.